TRPV1 and cancer: There is an increase in TRPV1 expression in the DRG of animals with cancer-induced bone pain (113–116), and pharmacological blockade of TRPV1 attenuates cancer-induced bone pain (23, 113), suggesting that TRPV1 activation plays a critical role in the generation of at least some types of bone pain.